Asset Details
Do you wish to reserve the book?
Hydrogen Sulfide: Recent Progression and Perspectives for the Treatment of Diabetic Nephropathy
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Hydrogen Sulfide: Recent Progression and Perspectives for the Treatment of Diabetic Nephropathy
Do you wish to request the book?
Hydrogen Sulfide: Recent Progression and Perspectives for the Treatment of Diabetic Nephropathy
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Hydrogen Sulfide: Recent Progression and Perspectives for the Treatment of Diabetic Nephropathy
2019
Overview
Diabetic kidney disease develops in approximately 40% of diabetic patients and is a major cause of chronic kidney diseases (CKD) and end stage kidney disease (ESKD) worldwide. Hydrogen sulfide (H2S), the third gasotransmitter after nitric oxide (NO) and carbon monoxide (CO), is synthesized in nearly all organs, including the kidney. Though studies on H2S regulation of renal physiology and pathophysiology are still in its infancy, emerging evidence shows that H2S production by renal cells is reduced under disease states and H2S donors ameliorate kidney injury. Specifically, aberrant H2S level is implicated in various renal pathological conditions including diabetic nephropathy. This review presents the roles of H2S in diabetic renal disease and the underlying mechanisms for the protective effects of H2S against diabetic renal damage. H2S may serve as fundamental strategies to treat diabetic kidney disease. These H2S treatment modalities include precursors for H2S synthesis, H2S donors, and natural plant-derived compounds. Despite accumulating evidence from experimental studies suggests the potential role of the H2S signaling pathway in the treatment of diabetic nephropathy, these results need further clinical translation. Expanding understanding of H2S in the kidney may be vital to translate H2S to be a novel therapy for diabetic renal disease.
Publisher
MDPI AG,MDPI
Subject
/ Diabetes
/ Diabetic Nephropathies - drug therapy
/ Diabetic Nephropathies - etiology
/ Diabetic Nephropathies - metabolism
/ Diabetic Nephropathies - pathology
/ Drug Evaluation, Preclinical
/ Enzymes
/ Fibrosis
/ Humans
/ Hydrogen Sulfide - chemistry
/ Hydrogen Sulfide - metabolism
/ Hydrogen Sulfide - pharmacology
/ Hydrogen Sulfide - therapeutic use
/ Hypoxia
/ Kidney Glomerulus - drug effects
/ Kidney Glomerulus - metabolism
/ Kidney Glomerulus - pathology
/ Kinases
/ Metabolic Networks and Pathways - drug effects
/ Oxidative Stress - drug effects
/ Proteins
/ Review
/ Sodium
